2011
DOI: 10.1007/s00044-011-9786-y
|View full text |Cite
|
Sign up to set email alerts
|

Structure-based design, synthesis, and molecular modeling studies of 1-(benzo[d]thiazol-2-yl)-3-(substituted aryl)urea derivatives as novel anti-Parkinsonian agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(3 citation statements)
references
References 39 publications
0
3
0
Order By: Relevance
“…Furfuryl (240), 2-and/or 3- methoxy (241), substituted phenyl derivatives emerged as potent antiParkinsonian agents. SAR study reveals, 2-chloro, 5-trifluoromethyl-substituted analog, halogen substituted in the phenyl ring exhibited less effective/moderate antiParkinsonian activity [276]. Biphenylbenzothiazole-2-carboxamide derivatives were synthesized and evaluated for their diuretic potential.…”
Section: Bta As Antidepressants Agentsmentioning
confidence: 99%
“…Furfuryl (240), 2-and/or 3- methoxy (241), substituted phenyl derivatives emerged as potent antiParkinsonian agents. SAR study reveals, 2-chloro, 5-trifluoromethyl-substituted analog, halogen substituted in the phenyl ring exhibited less effective/moderate antiParkinsonian activity [276]. Biphenylbenzothiazole-2-carboxamide derivatives were synthesized and evaluated for their diuretic potential.…”
Section: Bta As Antidepressants Agentsmentioning
confidence: 99%
“…The docking protocol used in the present study was therefore validated by docking all native co-crystallized ligand molecules to their respective proteins (PDB code: 1JXA, 1YXD, 1JIJ, 1HNJ, 4UAG and 3U2K). According to the method of validation, if the RMSD (root mean square deviation) of the best docked conformation is ≤2.0 Å from the experimental one, the used scoring function is successful [16][17][18]. The RMSD values of the native cocrystallized ligands after docking were ≤2.0 Å (data not shown), which confirms the reliability of AutoDock for docking compound 3 into crystal structures of different antibacterial drug targets.…”
mentioning
confidence: 70%
“…For instance, frentizole (I, Figure 2) acts as an immunosuppressant and is used for the treatment of Alzheimer's disease (AD), behaving as a weak inhibitor of the Aβ-ABAD interaction (IC 50 = 200 µM) [32]. Some diarylureas bearing a BTA moiety were studied for the treatment of Parkinson's disease (PD) as they showed high activity in alleviating haloperidol-induced catalepsy and oxidative stress in mice (II, Figure 2) [33]. The thiourea-containing benzothiazole derivative III, depicted in Figure 2, showed high antiproliferative activity against the human cell line U-937 (human macrophage cell line) when compared to standard drug etoposide [34].…”
Section: Introductionmentioning
confidence: 99%